|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
2/2002
vol. 1 abstract:
Clinical consequences of polycystic ovary syndrome in menopause
Beata Banaszewska
,
Leszek Pawelczyk
,
Monika Serdyńska
,
Robert Spaczyński
(Prz Menopauz 2002, 2: 7–13)
Online publish date: 2004/03/03
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Polycystic ovary syndrome (PCOS) is the most common endocrine abnormality of premenopausal women. It has been established that hyperinsulinaemia is a fundamental disturbance in many women with polycystic ovary syndrome and has significant metabolic effect that could have an impact after the menopause. Women with a history of PCOS have higher levels of several cardiovascular risk factors including hyperlipidemia, diabetes, hypertension. Additionally, endometrial cancer, due to unopposed estrogen action is more common in patients with polycystic ovary syndrome. Early prevention and treatment of PCOS patients may avoid many serious postmenopausal consequnces.
|
 |
